Allarity Therapeutics (ALLR) Earnings Analysis

Allarity Therapeutics (ALLR) next reports earnings on 2026-08-21, consensus EPS -0.25 USD. Last quarter (2026-05-15) it beat with EPS -0.17 USD vs -0.22 USD est (+22.7%). It has beaten estimates in 6/7 recent quarters (86%). Trailing P/E -1.78.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ALLR next report earnings?

Next earnings date2026-08-21
Consensus EPS estimate-0.25 USD
Revenue estimate0.00B

ALLR earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-15-0.17 USD-0.22 USD+22.7%Beat
2026-03-31-0.19 USD-0.22 USD+13.6%Beat
2025-11-14-0.19 USD-0.23 USD+17.4%Beat
2025-08-15-0.15 USD-0.21 USD+28.6%Beat
2025-05-09-0.25 USDn/an/an/a
2025-04-04-4.72978 USD-8.1 USD+41.6%Beat
2024-11-14-7.71 USD-8.52 USD+9.5%Beat
2024-08-05-3.3 USD-0.29 USD-1037.9%Miss

Beat rate: 6/7 (86%) over reported quarters with consensus data.

ALLR valuation and analyst view

Trailing P/E-1.78
Trailing EPS-0.70445 USD
Price / book2.95
Dividend yield0.00%
Market cap0.02B
Analyst consensusBuy (1 buy / 1 hold / 0 sell)

Related research pages

Frequently asked questions

When is Allarity Therapeutics (ALLR)'s next earnings date?

Allarity Therapeutics is next scheduled to report on 2026-08-21, with a consensus EPS estimate of -0.25 USD and revenue estimate of 0.00B.

Did ALLR beat earnings last quarter?

In its 2026-05-15 report, ALLR posted EPS of -0.17 USD versus a -0.22 USD estimate — a beat of 22.7%.

What is ALLR's earnings track record?

Over the last 7 reported quarters with consensus data, ALLR beat estimates 6 times (86%).

What is ALLR's current P/E ratio and EPS?

ALLR trades at a trailing P/E of -1.78 on trailing EPS of -0.7044453702897143 USD.

What do analysts rate ALLR?

Analyst consensus is "Buy" across 2 ratings (0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell).